Abstract
BackgroundImmunotherapy has facilitated great breakthroughs in the treatment of hepatocellular carcinoma (HCC). However, the efficacy and response rate of immunotherapy are limited and vary among different patients with HCC. TP53...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have